Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Xuelei Ma"'
Autor:
Haitao, Ding, Ping, Tan, Shiqin, Fu, Xiaohe, Tian, Hu, Zhang, Xuelei, Ma, Zhongwei, Gu, Kui, Luo
Publikováno v:
Journal of Controlled Release. 348:206-238
Microenvironment-responsive drug delivery systems (DDSs) can achieve targeted drug delivery, reduce drug side effects and improve drug efficacies. Among them, pH-responsive DDSs have gained popularity since the pH in the diseased tissues such as canc
Publikováno v:
Frontiers in Immunology. 13
Human papillomaviruses (HPVs) have been recognized as the etiologic agents of various cancers and are called HPV-driven cancers. Concerning HPV-mediated carcinogenic action, gene therapy can cure cancer at the molecular level by means of the correcti
Autor:
Xingyu Hou, Dan Zhong, Hongying Chen, Zhongwei Gu, Qiyong Gong, Xuelei Ma, Hu Zhang, Hongyan Zhu, Kui Luo
Publikováno v:
Carbohydrate polymers. 292
Rapid development of stimuli-responsive drug delivery systems (DDSs) for tumor therapy has raised increasing interest in recent decades, and many nanomedicines are prepared to achieve accurate or sustained drug release. However, the fabrication proce
Autor:
Xupeng Wang, Hao Zeng, Huaying Chen, Xiangtian Ma, Xuelei Ma, Ning Zhu, Heyu Xue, Linyan Chen
Publikováno v:
Oncology Nursing Forum. 48:81-93
Objectives To estimate the effectiveness of combining facial expression recognition and machine learning for better detection of distress. Sample & setting 232 patients with cancer in Sichuan University West China Hospital in Chengdu, China. Methods
Publikováno v:
Cancer Medicine, Vol 8, Iss 4, Pp 1389-1400 (2019)
Cancer Medicine
Cancer Medicine
Background Palbociclib is a small‐molecule, cyclin‐dependent kinase 4 and 6 inhibitor, which prevents phosphorylation of the retinoblastoma (Rb) protein and inhibits cell‐cycle progression from G1 to S phase. We performed this meta‐analysis t
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Background CC chemokine receptor 4 (CCR4), the receptor for CCL22 and CCL17, is expressed on the surface of effector Tregs that have the highest suppressive effects on antitumor immune response. CCR4 is also widely expressed on the surface of tumor c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ccd800f5df42454f183e7b473ed1202
https://doi.org/10.21203/rs.3.rs-50776/v1
https://doi.org/10.21203/rs.3.rs-50776/v1
Publikováno v:
Drug Design, Development and Therapy
Hui Yang,1,2,* Kai Shen,3,* Chenjing Zhu,3 Qingfang Li,3 Yunuo Zhao,2 Xuelei Ma3,* 1Cancer Center, West China Hospital, Sichuan University, Chengdu, People’s Republic of China; 2West China School of Medicine, West China Hospital, Sichuan University
Publikováno v:
Molecular Cancer
Molecular Cancer, Vol 18, Iss 1, Pp 1-28 (2019)
Molecular Cancer, Vol 18, Iss 1, Pp 1-28 (2019)
Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling is one of the most important intracellular pathways, which can be considered as a master regulator for cancer. Enormous efforts have been dedicated to the develop
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-6 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-6 (2018)
Background Negative feelings, such as anxiety and depression, are common in patients with cancer. Our aim was to investigate the prevalence of malnutrition and distress in cancer patients and to examine the relationship between them. Materials and me
Publikováno v:
Biochimica et biophysica acta. Reviews on cancer. 1871(2)
The chemokine receptor CXCR2 and its ligands are implicated in the progression of tumours and various inflammatory diseases. Activation of the CXCLs/CXCR2 axis activates multiple signalling pathways, including the PI3K, p38/ERK, and JAK pathways, and